Boehringer Ingelheim's top prescription drugs 2016-2018

This statistic shows revenues of Boehringer Ingelheim's top prescription drugs from 2016 to 2018. In 2018, revenue of top product Spiriva stood at approximately 2.4 billion euros. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany.

Revenues of Boehringer Ingelheim's top prescription drugs from 2016 to 2018

201620172018
----
----
----
----
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2019

Region

Worldwide

Survey time period

2016 to 2018

Supplementary notes

2016 figures were added from the previous annual report.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Top pharmaceutical drugs"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.